IPR ECOSYSTEM

Role of Strong IPR Framework in Driving India’s Atmanirbharta

In addition to producing 20% of all generic medications, the country also produces 60% of all vaccines used worldwide. Economic Survey 2020-21 predicts that the Indian pharmaceutical business will grow to USD 65 billion by 2024 and USD 130 billion by 2030. As pharmaceutical corporations intensify up efforts to change the Indian healthcare system, a strong IPR environment would be essential.